China's economic growth has skyrocketed during the last 15 years. In the second quarter of 2010, China's nominal gross domestic product (GDP) of $1.33 trillion surpassed that of Japan, $1.29 trillion. Along with the economic surge, China's healthcare market also is growing.... Read More
The SFDA issued “Requirements on Application Dossiers in Common Technical Document (CTD) Format for Pharmaceutical Products” in late September 2010. The release of this CDT format for Pharmaceutical Registration Applications continues China’s trend of integrating with international regulatory standards. Through further integration,... Read More
Since 2007, the United States Food and Drug Administration (FDA) has been working more closely with China’s primary medical regulatory authority, the State Food and Drug Administration (SFDA) to increase regulatory control of imported and exported medical goods. Regulatory harmonization deals such... Read More
The global recession has left medical companies scrambling to find new markets. China's GDP, adjusted for purchasing power parity, is currently second in the world and has surpassed Japan's. Medical companies should focus on this growing market. However, before entering the Chinese... Read More
Asia's cases of diabetes are at an all-time high. The International Diabetes Federation (IDF) estimates that more than 125 million people in Asia are suffering from the condition this year. These numbers are climbing quickly. There likely will be more than 200... Read More
The World Health Organization (WHO) recently released the “Global Adult Tobacco Survey.” It includes statistics on smoking in China that represent the entire country. The study indicates that smoking among men in China (regardless of age) continue to occur at very high... Read More
The 2010 Chinese Pharmacopoeia is a new and revised version of the 2005 Chinese Pharmacopoeia. Completed in 2009, it will come into effect October 1, 2010. Manufacturers in each Chinese province are expected to adhere to the contents. One of the most... Read More
Introduction With the United States emerging very slowly from a huge recession, some of Europe unable to pay its bills, and more restrictions coming from the US Food and Drug Administration (FDA), an area where medical device companies may want to focus... Read More
The deputy chief of China’s State Food and Drug Administration (SFDA), Zhang Jingli, has been removed from his post and is being investigated by an anti-corruption body, the Party of China Central Commission for Discipline Inspection. Zhang, who has held the position... Read More
Diabetes cases are dramatically on the rise in countries throughout Asia. The financially privileged city-dwellers tend to be the ones who have been identified as diabetics. Causes include insufficient exercise, high fat diets that have increasingly incorporated fast food items, genetics and... Read More